Researchers in Germany found a “relationship between a sudden increase in suicidality, anxiety symptoms, medication dosing and clinician and patient-rated akathisia” in patients with a first-episode diagnosis of schizophrenia who were treated with Haldol or Risperdal. Results were published online May 21, 2012 in Pharmocopsychiatry.
Seemuller, F. Lewitzka, U. Bauer, M. et. al; The Relationship of Akathisia with Treatment Emergent Suicidality among Patients with First-Episode Schizophrenia Treated with Haloperidol or Risperidone, Pharmacopsychiatry, published online May 21, 2012
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.